235 related articles for article (PubMed ID: 27833027)
1. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.
Huang AC; Yang MD; Hsiao YT; Lin TS; Ma YS; Peng SF; Hsia TC; Cheng YD; Kuo CL; Chung JG
J Ethnopharmacol; 2016 Dec; 194():1043-1050. PubMed ID: 27833027
[TBL] [Abstract][Full Text] [Related]
2. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG
Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205
[TBL] [Abstract][Full Text] [Related]
3. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
[TBL] [Abstract][Full Text] [Related]
4. [Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].
Kang X; Lu P; Cui Y; Wang Y; Zhang Q; Gong Y; Xu Z
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):490-6. PubMed ID: 26463323
[TBL] [Abstract][Full Text] [Related]
5. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
Zhao HJ; Liu T; Mao X; Han SX; Liang RX; Hui LQ; Cao CY; You Y; Zhang LZ
Acta Pharmacol Sin; 2015 Jun; 36(6):758-68. PubMed ID: 25864648
[TBL] [Abstract][Full Text] [Related]
6. Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways.
Chen YY; Lu HF; Hsu SC; Kuo CL; Chang SJ; Lin JJ; Wu PP; Liu JY; Lee CH; Chung JG; Chang JB
Environ Toxicol; 2015 Jan; 30(1):74-82. PubMed ID: 23949904
[TBL] [Abstract][Full Text] [Related]
7. Benzyl Isothiocyanate Induces Apoptotic Cell Death Through Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells
Huang YP; Jiang YW; Chen HY; Hsiao YT; Peng SF; Chou YC; Yang JL; Hsia TC; Chung JG
Anticancer Res; 2018 Sep; 38(9):5165-5176. PubMed ID: 30194164
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
9. Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-[Formula: see text]B Signaling Pathways.
Hsiao YT; Fan MJ; Huang AC; Lien JC; Lin JJ; Chen JC; Hsia TC; Wu RS; Chung JG
Am J Chin Med; 2018; 46(1):209-229. PubMed ID: 29402127
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin Impairs Cell Migration and Invasion of Human Lung Cancer NCI-H460 Cells via UPA and MAPK Signaling Pathways.
Hsia TC; Yu CC; Hsiao YT; Wu SH; Bau DT; Lu HF; Huang YP; Lin JG; Chang SJ; Chung JG
Anticancer Res; 2016 Nov; 36(11):5989-5997. PubMed ID: 27793925
[TBL] [Abstract][Full Text] [Related]
11. [Effect of bufalin combined gefitinib on lung cancer H1975 cells and its mechanisms research].
Kang XH; Gong YB; Wang LF; Wang ZQ; Deng HB; Zhao XZ; Wu J; Xu ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Aug; 33(8):1081-5. PubMed ID: 24325059
[TBL] [Abstract][Full Text] [Related]
12. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions.
Hong SH; Kim GY; Chang YC; Moon SK; Kim WJ; Choi YH
Int J Oncol; 2013 Jan; 42(1):277-86. PubMed ID: 23128598
[TBL] [Abstract][Full Text] [Related]
13. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.
Qiu DZ; Zhang ZJ; Wu WZ; Yang YK
BMC Complement Altern Med; 2013 Jul; 13():185. PubMed ID: 23870199
[TBL] [Abstract][Full Text] [Related]
14. Phenethyl Isothiocyanate Induces Apoptotic Cell Death Through the Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells
Hsia TC; Huang YP; Jiang YW; Chen HY; Cheng ZY; Hsiao YT; Chen CY; Peng SF; Chueh FS; Chou YC; Chung JG
Anticancer Res; 2018 Apr; 38(4):2137-2147. PubMed ID: 29599332
[TBL] [Abstract][Full Text] [Related]
15. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.
Han SY; Zhao MB; Zhuang GB; Li PP
Lung Cancer; 2012 Jan; 75(1):30-7. PubMed ID: 21757251
[TBL] [Abstract][Full Text] [Related]
16. Bufalin induces cell death in human lung cancer cells through disruption of DNA damage response pathways.
Wu SH; Wu TY; Hsiao YT; Lin JH; Hsu SC; Hsia TC; Yang ST; Hsu WH; Chung JG
Am J Chin Med; 2014; 42(3):729-42. PubMed ID: 24871662
[TBL] [Abstract][Full Text] [Related]
17. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG
Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288
[TBL] [Abstract][Full Text] [Related]
18. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
Ho CC; Lai KC; Hsu SC; Kuo CL; Ma CY; Lin ML; Yang JS; Chung JG
Hum Exp Toxicol; 2011 Apr; 30(4):296-306. PubMed ID: 20498032
[TBL] [Abstract][Full Text] [Related]
19. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Wu M; Yuan Y; Pan YY; Zhang Y
Mol Med Rep; 2014 Aug; 10(2):931-8. PubMed ID: 24840891
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
